• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The Lancet Infect Dis. Applying lessons from SARS to a newly identified coronavirus

Giuseppe

Emeritus
[Source: The Lancet Infectious Diseases, full text: (LINK). Extract, edited.]

The Lancet Infectious Diseases, Early Online Publication, 21 March 2013

doi:10.1016/S1473-3099(13)70082-3

Applying lessons from SARS to a newly identified coronavirus

Original Text


Brian McCloskey a, Alimuddin Zumla b, Gwen Stephens d, David L Heymann c, Ziad A Memish d e



Human infection with a newly identified novel coronavirus has rapidly focused global attention on risk assessment 1?6 because its epidemic potential is not known. First detected in September, 2012, in a patient who had died of an acute respiratory illness in Saudi Arabia, 4 it was soon confirmed in a Qatari patient with a similar illness in London, UK. These cases triggered collaborations between the Kingdom of Saudi Arabia Ministry of Health (KSA-MoH), Qatar, and other global partners. The immediat ...
__________

a WHO Collaborating Centre on Mass Gatherings and Health Protection Agency, UK; b Division of Infection and Immunity, University College London, London, UK; c Centre on Global Health Security Chatham House, and London School of Hygiene and Tropical Medicine, London, UK; d WHO Collaborating Centre for Mass Gathering Medicine, Ministry of Health, Saudi Arabia; e Al-Faisal University, Riyadh, Saudi Arabia
-
------
 
Back
Top